166 related articles for article (PubMed ID: 35364761)
1. Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD.
Ciardullo S; Bianconi E; Cannistraci R; Parmeggiani P; Marone EM; Perseghin G
J Endocrinol Invest; 2022 Aug; 45(8):1547-1553. PubMed ID: 35364761
[TBL] [Abstract][Full Text] [Related]
2. Low ankle-brachial index is associated with higher cardiovascular mortality in individuals with nonalcoholic fatty liver disease.
Xiong G; Guo L; Li L; Liang M
Eur J Med Res; 2024 May; 29(1):276. PubMed ID: 38730507
[TBL] [Abstract][Full Text] [Related]
3. Screen-detected abnormal ankle brachial index: A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease.
Jagt VL; Hazenberg CEVB; Kapelle J; Cramer MJ; Visseren FLJ; Westerink J;
PLoS One; 2022; 17(3):e0265050. PubMed ID: 35271641
[TBL] [Abstract][Full Text] [Related]
4. Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes.
Zou Y; Li X; Wang C; Wang J; Wang F; Ma L; You W; Li C
Intern Med J; 2017 Oct; 47(10):1147-1153. PubMed ID: 28696562
[TBL] [Abstract][Full Text] [Related]
5. Association of High Ankle Brachial Index With Incident Cardiovascular Disease and Mortality in a High-Risk Population.
Hendriks EJ; Westerink J; de Jong PA; de Borst GJ; Nathoe HM; Mali WP; van der Graaf Y; van der Schouw YT; Beulens JW;
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):412-7. PubMed ID: 26715681
[TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease.
Wang B; Zhao Z; Liu S; Wang S; Chen Y; Xu Y; Xu M; Wang W; Ning G; Li M; Wang T; Bi Y
Diabetes Res Clin Pract; 2021 Jul; 177():108873. PubMed ID: 34051282
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study.
Garimella PS; Ix JH; Katz R; Chonchol MB; Kestenbaum BR; de Boer IH; Siscovick DS; Shastri S; Hiramoto JS; Shlipak MG; Sarnak MJ
Atherosclerosis; 2014 Mar; 233(1):91-6. PubMed ID: 24529128
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Artery Disease and Risk of Fibrosis Deterioration in Nonalcoholic Fatty Liver Disease: A Prospective Investigation.
Zhu W; Deng CJ; Xuan LP; Dai HJ; Zhao ZY; Wang TG; Li M; Lu JL; Xu Y; Chen YH; Wang WQ; Bi YF; Xu M
Biomed Environ Sci; 2020 Apr; 33(4):217-226. PubMed ID: 32438959
[TBL] [Abstract][Full Text] [Related]
9. Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease.
Wu W; Xiang J; Chen X
Front Endocrinol (Lausanne); 2021; 12():773342. PubMed ID: 34992579
[TBL] [Abstract][Full Text] [Related]
10. Effects of Three Different Methods Defining Onset of Peripheral Artery Disease on the Assessments of Incidence and Important Predictors - Results from the German Epidemiological Trial on Ankle Brachial Index (getABI).
Lupilov A; Krause D; Klaassen-Mielke R; Trampisch HJ; Rudolf H
Vasc Health Risk Manag; 2021; 17():421-429. PubMed ID: 34335027
[TBL] [Abstract][Full Text] [Related]
11. Association of borderline ankle-brachial index with mortality and the incidence of peripheral artery disease in diabetic patients.
Natsuaki C; Inoguchi T; Maeda Y; Yamada T; Sasaki S; Sonoda N; Shimabukuro M; Nawata H; Takayanagi R
Atherosclerosis; 2014 Jun; 234(2):360-5. PubMed ID: 24732575
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
Golabi P; Paik J; Reddy R; Bugianesi E; Trimble G; Younossi ZM
BMC Gastroenterol; 2019 Apr; 19(1):56. PubMed ID: 30991959
[TBL] [Abstract][Full Text] [Related]
13. Association of serum uric acid with all-cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease.
Yang S; Ye Z; Liu M; Zhang Y; Wu Q; Zhou C; Zhang Z; He P; Zhang Y; Li H; Liu C; Qin X
Clin Endocrinol (Oxf); 2023 Jan; 98(1):49-58. PubMed ID: 35968564
[TBL] [Abstract][Full Text] [Related]
14. Ankle-brachial index, toe-brachial index, and cardiovascular mortality in persons with and without diabetes mellitus.
Hyun S; Forbang NI; Allison MA; Denenberg JO; Criqui MH; Ix JH
J Vasc Surg; 2014 Aug; 60(2):390-5. PubMed ID: 24657294
[TBL] [Abstract][Full Text] [Related]
15. Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality.
Criqui MH; Ninomiya JK; Wingard DL; Ji M; Fronek A
J Am Coll Cardiol; 2008 Nov; 52(21):1736-42. PubMed ID: 19007695
[TBL] [Abstract][Full Text] [Related]
16. In postmenopausal women, lower limb peripheral arterial disease, assessed by ankle-brachial index, may be a strong predictor of cardiovascular risk.
Buso G; Darioli R; Calanca L; Depairon M; Schwitter J; Mazzolai L; Alatri A
Eur J Intern Med; 2022 May; 99():63-69. PubMed ID: 35135705
[TBL] [Abstract][Full Text] [Related]
17. The Walking Impairment Questionnaire stair-climbing score predicts mortality in men and women with peripheral arterial disease.
Jain A; Liu K; Ferrucci L; Criqui MH; Tian L; Guralnik JM; Tao H; McDermott MM
J Vasc Surg; 2012 Jun; 55(6):1662-73.e2. PubMed ID: 22608041
[TBL] [Abstract][Full Text] [Related]
18. Ankle-brachial index predicts renal outcomes and all-cause mortality in high cardiovascular risk population: a nationwide prospective cohort study in CORE project.
Aiumtrakul N; Supasyndh O; Krittayaphong R; Phrommintikul A; Satirapoj B
Int Urol Nephrol; 2022 Jul; 54(7):1641-1652. PubMed ID: 34724144
[TBL] [Abstract][Full Text] [Related]
19. Ankle Brachial Index (ABI) predicts 2-year mortality risk among older adults in the Republic of Congo: The EPIDEMCA-FU study.
Samba H; Guerchet M; Ndamba-Bandzouzi B; Kehoua G; Mbelesso P; Desormais I; Aboyans V; Preux PM; Lacroix P
Atherosclerosis; 2019 Jul; 286():121-127. PubMed ID: 31136913
[TBL] [Abstract][Full Text] [Related]
20. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
Chinnadurai R; Chrysochou C; Kalra PA
Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
